Abola, P., & Jabishvili, G. (2025). Incidence of adverse and safety events in individuals with Parkinson’s disease treated with catechol-o-methyltransferase inhibitor opicapone as an add-on to levodopa treatment: a systematic review and meta-analysis. Prospects in Pharmaceutical Sciences, 23(4), 175–185. https://doi.org/10.56782/pps.563